Authors: Mainwaring, PN Cunningham, D Gregory, W Hoskin, P Hancock, B Norton, AJ MacLennan, K Smith, P Hudson, GV Linch, D

Citation: Pn. Mainwaring et al., Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen forpatients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdfiaCEBO versus PMitCEBO, BLOOD, 97(10), 2001, pp. 2991-2997

Authors: Sumpter, K Powles, RL Raje, N Ramiah, V Kulkarni, S Treleaven, J Mainwaring, PN

Citation: K. Sumpter et al., Oral idarubicin as a single agent therapy in patients with relapsed or resistant multiple myeloma, LEUK LYMPH, 35(5-6), 1999, pp. 593-597

Authors: Mainwaring, PN Dowsett, M

Citation: Pn. Mainwaring et M. Dowsett, LHRH superagonists and antagonists in the treatment of breast cancer, CONT ENDOC, 11, 1999, pp. 313-328